Advertising That federal support of research through grants to the University ... to run the Department of Health and Human Services is of particular concern among biotech leaders.

Barclays analyst Gena Wang maintained a Buy rating on Legend Biotech (LEGN – Research Report) today and set a price target of $94.00. The company’s shares closed last Friday at $36.91.

DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions ...

The BioXplorer 100 from H.E.L is a multi-bioreactor system that has been specifically developed for the optimization of aerobic fermentations. Having a working volume as low as 50 mL, the ...

As the first week of Trump’s second term gets underway, the not-quite-real Department of Government Efficiency is both struggling and expanding its remit. By Steve Benen About a month after ...

WASHINGTON, Jan 27 (Reuters) - The Trump administration has removed the U.S. Justice Department's senior career ethics official from his post, according to a person familiar with the matter ...

Navigating biotech funding in 2025: Expert advice and trends In addition to our biotech funding tracker, we offer expert advice and trend articles to help you navigate the investment landscape. You ...

For proof, look no further than the colors it chooses for the Super Bowl logo. The premise of the alleged conspiracy is that the colors in the NFL's official Super Bowl logo correspond to the ...

The IPO comes amid a stuttering acceleration in the number of biotech companies seeking public listings after a two-year lull, with a pick-up in the first quarter of 2024 that lost some momentum ...

Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

4D Molecular Therapeutics Inc. 1.29% $218.19M ...